Oxra 10 Tablet Information
Oxra 10 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Diabetes Type 2.
Medical history of the patient along with age and gender determines the dosage of Oxra 10 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Oxra 10 Tablet as well, which are listed below. Normally, these side effects of Oxra 10 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Oxra 10 Tablet's effect during pregnancy is Severe and Unknown while nursing. In addition, Oxra 10 Tablet's effects on the liver, heart and kidney are discussed below in the Oxra 10 Tablet related warnings section.
Oxra 10 Tablet is contraindicated in people with pre-existing medical conditions like Bladder Cancer, Kidney Disease as it can result in adverse effects. Other contraindications of Oxra 10 Tablet have been discussed in the sections ahead.
Drug reaction of Oxra 10 Tablet with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Oxra 10 Tablet is safe while driving, and is is addictive in nature.
Oxra 10 Tablet Benefits & Uses
Oxra 10 Tablet is used to treat the following -
Main Benefits
- Diabetes Type 2
Oxra 10 Tablet Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Oxra 10 Tablet Side Effects
Based on research, the following side effects have been observed when Oxra 10 Tablet is used -
Severe
- Urinary tract infection
Moderate
- Hypoglycemia (Low blood sugar level)
- Confusion
- Tachycardia
- Depression (Read More - From Meditation to Nutrition: Home Remedies for Easing Depression)
Mild
- Nausea or vomiting
- Dizziness (Read More - Home Remedies for Dizziness: Quick Tips for Instant Relief)
- Weight gain
- Dry Mouth
- Stomach ache (Read More - Home remedies for stomach pain)
- Fever (Read More - Home remedies for fever)
Oxra 10 Tablet Related Warnings
-
Is the use of Oxra 10 Tablet safe for pregnant women?
Oxra should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Severe -
Is the use of Oxra 10 Tablet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Oxra for breastfeeding women are not known.
Unknown -
What is the effect of Oxra 10 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Oxra. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
Moderate -
What is the effect of Oxra 10 Tablet on the Liver?
Oxra can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
Moderate -
What is the effect of Oxra 10 Tablet on the Heart?
In the absence of any scientific study on the side effects of Oxra on the heart, information on safety of Oxra for the heart is unavailable.
Unknown
Severe Interaction of Oxra 10 Tablet with Other Drugs
Oxra 10 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
- Novorapid 100IU/ml Solution for Injection
- Novorapid Flexpen 100U/ml
- Novomix 30 Flexpen 100IU/ml 3ml
- Novomix 30 100IU/ml Penfill 3ml
- Novorapid 100IU/ml Solution for Injection
- Novorapid Flexpen 100U/ml
- Novomix 30 Flexpen 100IU/ml 3ml
- Novomix 30 100IU/ml Penfill 3ml
Oxra 10 Tablet Contraindications
If you are suffering from any of the following diseases, you should not take Oxra 10 Tablet unless your doctor advises you to do so -
- Bladder Cancer
- Kidney Disease
- High Lipoprotein
- Low Blood Pressure
- Bladder Cancer
- Kidney Disease
- High Lipoprotein
- Low Blood Pressure
- Bladder Cancer
- Kidney Disease
- High Lipoprotein
- Low Blood Pressure
Frequently asked Questions about Oxra 10 Tablet
-
Is this Oxra 10 Tablet habit forming or addictive?
No, you will not get addicted to Oxra 10 Tablet.
No -
Is it safe to drive or operate heavy machinery when consuming?
Oxra 10 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Safe -
Is it safe?
Oxra 10 Tablet should be used only after doctor's advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
Oxra 10 Tablet is unable to treat or cure mental disorders.
No
Oxra 10 Tablet Interactions with Food and Alcohol
-
Interaction between Food and Oxra 10 Tablet
There isn't any research available on the side effects of taking Oxra 10 Tablet with food.
Unknown -
Interaction between Alcohol and Oxra 10 Tablet
Taking alcohol with Oxra 10 Tablet can be dangerous.
Severe
See all substitutes for Oxra
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278